GeneTex

  • Country / Location Selection

United States (US)

FOXO3A blocking peptide

Cat. No. GTX17026-PEP

Species

 Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX17026.

PROPERTIES

Form

Lyophilized powder

Buffer

Reconstitute with 200μl distilled water to obtain a 0.5mg/ml peptide solution. Lyophilized from 5% (v/v) acetonitrile/H₂O.

Preservative

No preservative

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

C-GAKQASSQSWVPG

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Forkhead Box O3 , Af6Q21 , Fkhrl1 , Fkhrl1P2 , Foxo2 , Foxo3A , Foxo3

Background

This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. This gene likely functions as a trigger for apoptosis through expression of genes necessary for cell death. Translocation of this gene with the MLL gene is associated with secondary acute leukemia. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for FOXO3A blocking peptide (GTX17026-PEP). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for FOXO3A blocking peptide (GTX17026-PEP). Be the first to share your experience with this product.
Submit a Review
Package List Price ($)
$ 239